⌘K

Home/Filings/4/0001179110-18-011555

4//SEC Filing

MILLIGAN DAVID V 4

Accession 0001179110-18-011555

CIK 0001157601other

View on SEC.gov Company Profile

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 4:25 PM ET

Size

6.5 KB

Accession

0001179110-18-011555

Insider Transaction Report

Form 4

Period: 2018-09-18

MADRIGAL PHARMACEUTICALS, INC.MDGL

MILLIGAN DAVID V

Director

Transactions

Exercise/Conversion
Common Stock
2018-09-18$9.45/sh+20,000$189,000→ 20,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2018-09-18−20,000→ 0 total
Exercise: $9.45From: 2017-07-22Exp: 2026-07-22→ Common Stock (20,000 underlying)

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

MADRIGAL PHARMACEUTICALS, INC.

CIK 0001157601

Entity typeother

Related Parties

1

filerCIK 0001222252

Filing Metadata

Form type: 4
Filed: Sep 18, 8:00 PM ET
Accepted: Sep 19, 4:25 PM ET
Size: 6.5 KB

View on SEC.gov